Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy

Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy

SHANGHAI, March 13, 2026 /PRNewswire/ -- On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S....

Beko Triumphs at iF DESIGN AWARDS 2025 with Six Wins Across Product, UX, and Communication

Beko Triumphs at iF DESIGN AWARDS 2025 with Six Wins Across Product, UX, and Communication

Beko excels at iF DESIGN AWARDS 2025, winning six accolades across Whirlpool, Grundig, and Indesit brands in Product, UX, and Communication categories, showcasing innovative and sustainable design ISTANBUL, March 13, 2025 /PRNewswire/ -- Beko...

menu
menu